Company Overview of AV Therapeutics, Inc.
AV Therapeutics, Inc. develops cancer therapeutics and immunotherapeutic vaccines. The company identifies and patents the Capridine, a chemotherapeutic drug that has shown in preclinical models to have specific activity against prostate and colon cancer. Its cancer therapeutics and immunotherapeutic vaccines could be used together with prevalent treatment modalities, such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. AV Therapeutics, Inc. was founded in 2011 and is headquartered in New York, New York.
20 East 68th Street
New York, NY 10065
Founded in 2011
Key Executives for AV Therapeutics, Inc.
AV Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Vicept Therapeutics Incorporated||United States|
|b3 bio, inc.||United States|
|Partikula LLC||United States|
|Valerion Therapeutics, LLC||United States|
|Q Therapeutics, Inc.||United States|
Recent Private Companies Transactions
April 4, 2014
December 17, 2013
|Merica Corp., Inc.|
December 13, 2013
To contact AV Therapeutics, Inc., please visit www.avth.net. Company data is provided by Capital IQ. Please use this form to report any data issues.